Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 3/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
| ▸ | TERT | O14746 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | FABP4 | P15090 | 2/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5613297 | 1.00 | EP300 (0.50) | EP300TSHRTHRBKMT2AMEN1 | |
| SCHEMBL5613602 | 1.00 | EP300 (0.50) | EP300TSHRTHRBKMT2AMEN1 | |
| SCHEMBL5613265 | 1.00 | EP300 (0.50) | EP300TSHRTHRBKMT2AMEN1 | |
| SCHEMBL5613298 | 1.00 | EP300 (0.50) | EP300TSHRTHRBKMT2AMEN1 | |
| SCHEMBL5613471 | 1.00 | EP300 (0.50) | EP300TSHRTHRBKMT2AMEN1 | |
| SCHEMBL2001842 | 1.00 | EP300 (0.50) | EP300TSHRTHRBKMT2AMEN1 | |
| SCHEMBL5613438 | 1.00 | EP300 (0.50) | EP300TSHRTHRBKMT2AMEN1 | |
| SCHEMBL5613262 | 1.00 | EP300 (0.50) | EP300TSHRTHRBKMT2AMEN1 | |
| SCHEMBL5613604 | 1.00 | EP300 (0.50) | EP300TSHRTHRBKMT2AMEN1 | |
| SCHEMBL5613417 | 1.00 | EP300 (0.50) | EP300TSHRTHRBKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101896445-A | Linear olefin isomer isomerization using molecular sieve catalysts | CHEVRON PHILLIPS CHEMICAL CO | 2010-11-24 | — | — | CN | disclosed |
| EP-2231564-A1 | LINEAR OLEFIN ISOMER ISOMERIZATION USING MOLECULAR SIEVE CATALYSTS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2010-09-29 | — | — | EP | disclosed |
| WO-2009085886-A1 | LINEAR OLEFIN ISOMER ISOMERIZATION USING MOLECULAR SIEVE CATALYSTS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2009-07-09 | — | — | WO | disclosed |
| US-20090163757-A1 | Linear olefin isomer isomerization using molecular sieve catalysts | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2009-06-25 | — | — | US | disclosed |
| US-20070270521-A1 | Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-11-22 | — | — | US | disclosed |
| CN-101024659-A | Transition metal compound, polymerization initiator system including same and polymer production method | SUMITOMO CHEMICAL CO (JP) | 2007-08-29 | — | — | CN | disclosed |
| US-6225437-B1 | USEFUL AS INTERNAL AND EXTERNAL SIZING AGENTS FOR PAPER AND PAPER PRODUCTS | ALBEMARLE CORPORATION | 2001-05-01 | — | — | US | disclosed |
| WO-2000078717-A1 | SIZING AGENTS OF ENHANCED PERFORMANCE CAPABILITIES | ALBEMARLE CORPORATION (US) | 2000-12-28 | — | — | WO | disclosed |
| WO-2000078714-A2 | SUCCINIMIDES AS PAPER SIZING AGENTS | ALBEMARLE CORPORATION (US) | 2000-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070270521-A1 | Transition metal compound, polymerization-initiator system comprising the same, and process for producing polymer | CARM1, CPN1, CCNT1 | EP300 1453/4885TSHR 4291/4885THRB 3489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.